How to Help Your Patients Save Money on Uzedy: A Provider's Guide to Savings Programs

For many patients prescribed Uzedy (risperidone extended-release injectable suspension), the cost of treatment can be a significant barrier to adherence — and in psychiatric care, non-adherence carries serious clinical consequences. This guide is written for prescribers, psychiatric nurses, clinic administrators, and social workers who want to equip patients with every available savings resource for Uzedy in 2026.

Understanding Uzedy's Cost Landscape

Uzedy's Wholesale Acquisition Cost (WAC) ranges from approximately $1,232 to over $3,080 per month for once-monthly doses. Once-every-2-month doses (100 mg through 250 mg) carry higher per-injection costs. As a brand-name only specialty injectable, there is no generic alternative, meaning cost savings must come through insurance coverage, manufacturer programs, or institutional pricing.

The key distinction for billing: because Uzedy is administered in a clinical setting, it is typically billed through the patient's medical benefit (e.g., Medicare Part B), NOT the pharmacy benefit. This affects which savings programs apply and how the claim is processed.

Savings Tool 1: Teva Total Support™ Copay Savings Offer

The Uzedy savings offer from Teva is the most powerful tool for commercially insured patients. Eligible patients may pay as little as $0 per dose.

Eligibility: Commercial (private) insurance only. NOT available for Medicare, Medicaid, TRICARE, or other government-funded insurance programs.

Enrollment: Enroll patients through Teva Total Support at 1-800-887-8100 (Monday–Friday, 9 AM–8 PM ET) or at Uzedy.com/savings-and-resources. Enrollment can be completed over the phone.

When to enroll: Enroll patients at the time of prescribing — before the first injection. Early enrollment prevents delays and ensures the savings are in place from the first dose.

Savings Tool 2: Teva's Patient Assistance Program (PAP) for Uninsured Patients

For patients who are uninsured or underinsured and do not qualify for the commercial savings offer, Teva's Patient Assistance Program may provide Uzedy at no cost. Your office should proactively screen patients for PAP eligibility at the time of prescribing, particularly for:

Uninsured patients

Patients in the Medicare coverage gap (donut hole), though Uzedy is usually Part B not Part D

Patients who have had commercial insurance lapse

Contact Teva Total Support (1-800-887-8100) to determine current PAP eligibility criteria and to initiate enrollment. Additional PAP resources include NeedyMeds.org and RxAssist.org.

Savings Tool 3: 340B Drug Pricing for Eligible Facilities

For 340B-covered entities (Federally Qualified Health Centers, community health centers, Ryan White clinics, certain hospitals), the 340B Drug Pricing Program allows purchase of outpatient drugs — including Uzedy — at significantly reduced prices, typically 30–50% below WAC. These savings can be passed on to eligible patients, making Uzedy dramatically more affordable.

If your facility is 340B-covered, work with your 340B administrator to confirm Uzedy eligibility and ensure appropriate split billing or in-house dispensing protocols are in place. Not all facilities take full advantage of 340B for specialty LAI antipsychotics — this can represent significant cost savings for your patient population.

Savings Tool 4: Medicare Part B Coverage

Because Uzedy is administered in a clinical setting, it is billed under Medicare Part B rather than Part D. Under Part B:

Medicare covers 80% of the allowed amount after the annual Part B deductible ($257 in 2026 — confirm current amount).

Patient is responsible for 20% coinsurance — which on Uzedy can still be hundreds of dollars per dose.

A Medigap (supplemental) plan covering Part B coinsurance can eliminate this cost entirely.

Medicare Extra Help (Low Income Subsidy): For patients with limited income and resources, the Extra Help program can reduce Medicare cost-sharing significantly. Assist patients in applying through the Social Security Administration (ssa.gov/extrahelp).

Important billing note: Uzedy is typically billed under the J3490 (unclassified drugs) or J3590 (unclassified biologics) code when an HCPCS code is not yet established, or under a drug-specific HCPCS code when assigned. Confirm the current billing code with your billing team and Teva Total Support.

Savings Tool 5: Medicaid Coverage

Medicaid coverage for Uzedy varies by state. In states that cover Uzedy, it may be available with low or no copay for Medicaid enrollees. Some states require prior authorization or step therapy (trial of another LAI first). For patients on Medicaid, assist with PA documentation early and appeal denials when clinically warranted. If your state Medicaid formulary does not cover Uzedy, discuss alternative LAI options with the patient.

Practical Workflow for Maximizing Patient Savings

Implement this workflow when prescribing Uzedy:

At time of prescribing: Contact Teva Total Support (1-800-887-8100) to initiate benefits investigation and prior authorization simultaneously.

For commercially insured patients: Enroll in the Uzedy savings offer immediately.

For uninsured or Medicare patients: Screen for PAP eligibility; check if your facility is 340B-covered; assist Medicare patients with Medigap and Extra Help options.

For Medicaid patients: Confirm Uzedy coverage in your state; initiate PA with diagnosis and clinical justification documentation; assist with appeals if denied.

Assign a care coordinator or social worker to manage savings enrollment for high-risk patients — those most likely to discontinue due to cost.

The Cost of Non-Adherence vs. the Cost of Savings Program Administration

The clinical and economic cost of a psychiatric relapse — including emergency visits, hospitalization, and functional decline — far exceeds the administrative effort of enrolling a patient in a savings program. Investing in savings program navigation at the start of treatment pays dividends in adherence and long-term outcomes. For more resources on helping patients access Uzedy, visit medfinder for providers — a service that helps patients find their medication at pharmacies near them.

For the clinical access side of the equation, see our companion guide: Uzedy Shortage: What Providers and Prescribers Need to Know in 2026.